World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
16233
World Ranking
13606
National Ranking
5773

Overview

Kevin G. Peters is affiliated with Procter & Gamble in the United States. Their research spans multiple disciplines within medicine and biochemistry, genetics, and molecular biology. The primary fields of study include Medicine with 25 publications and Biochemistry, Genetics and Molecular Biology with 12 publications.

The subfields of study cover Molecular Biology, Ophthalmology, Epidemiology, Oncology, and Cancer Research. Specific topics frequently addressed in Peters's work include:

  • Glaucoma and retinal disorders
  • Retinal Diseases and Treatments
  • Protein Tyrosine Phosphatases
  • Cancer, Hypoxia, and Metabolism
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • COVID-19 and healthcare impacts

Peters has contributed to research published in a variety of venues. Frequent publication outlets include:

  • Gastroenterology
  • Translational Vision Science & Technology
  • JCI Insight
  • American Journal of Ophthalmology
  • EMBO Molecular Medicine

The scientist's recent papers include:

  • "Tie2 Activation via VE-PTP Inhibition With Razuprotafib as an Adjunct to Latanoprost in Patients With Open Angle Glaucoma or Ocular Hypertension" (2022) published in Translational Vision Science & Technology
  • "Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19" (2021) published in JCI Insight
  • "VE-PTP inhibition elicits eNOS phosphorylation to blunt endothelial dysfunction and hypertension in diabetes" (2020) published in Cardiovascular Research
  • "Macular and Peripapillary Optical Coherence Tomography Angiography Metrics Predict Progression in Diabetic Retinopathy: A Sub-analysis of TIME-2b Study Data" (2020) published in American Journal of Ophthalmology
  • "A Small Molecule Inhibitor of VE-PTP Activates Tie2 in Schlemm's Canal Increasing Outflow Facility and Reducing Intraocular Pressure" (2020) published in Investigative Ophthalmology & Visual Science

Frequent co-authors collaborating with Kevin G. Peters include Akshay Buch, Dietmar Vestweber, Mitchell Brigell, Barbara Withers, and Astrid F. Nottebaum. These collaborators have contributed to several joint publications, indicating active and recurring partnerships across the scientist's projects.

Best Publications

  • Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium

    T P Quinn;K G Peters;C De Vries;N Ferrara

  • Large induction of keratinocyte growth factor expression in the dermis during wound healing

    Sabine Werner;Kevin G. Peters;Michael T. Longaker;Frances Fuller-Pace

  • Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse.

    K.G. Peters;S. Werner;G. Chen;L.T. Williams

  • Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth

    K G Peters;C De Vries;L T Williams

  • Unique Expression Pattern of the FGF Receptor 3 Gene during Mouse Organogenesis

    Kevin Peters;David Ornitz;Sabine Werner;Lewis Williams

  • Rescue of Diabetes-Related Impairment of Angiogenesis by Intramuscular Gene Therapy with Adeno-VEGF

    Alain Rivard;Marcy Silver;Dongfen Chen;Marianne Kearney

  • Targeted expression of a dominant negative FGF receptor blocks branching morphogenesis and epithelial differentiation of the mouse lung.

    K. Peters;S. Werner;Xiang Liao;S. Wert

  • Tie2 Expression and Phosphorylation in Angiogenic and Quiescent Adult Tissues

    Adrianne L. Wong;Zishan A. Haroon;Sabine Werner;Mark W. Dewhirst

  • Point mutation of an FGF receptor abolishes phosphatidylinositol turnover and Ca2+ flux but not mitogenesis.

    Kevin G. Peters;Jacky Marie;Jacky Marie;Emily Wilson;Harlan E. Ives

  • Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2

    Pengnian Lin;Jake A. Buxton;Ann Acheson;Czeslaw Radziejewski

  • Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities.

    S. Werner;D.-S. R. Duan;C. De Vries;K. G. Peters

  • Inhibition of tumor angiogenesis using a soluble receptor establishes a role for Tie2 in pathologic vascular growth.

    Pengnian Lin;Peter Polverini;Mark Dewhirst;Siqing Shan

  • Differential Expression of Tissue Factor Protein in Directional Atherectomy Specimens From Patients With Stable and Unstable Coronary Syndromes

    Brian H. Annex;Stephen M. Denning;Keith M. Channon;Michael H. Sketch

  • The zebrafish gene cloche acts upstream of a flk-1 homologue to regulate endothelial cell differentiation

    Wayne Liao;Brent W. Bisgrove;Holly Sawyer;Barbara Hug

  • Inhibition of tumor growth by targeting tumor endothelium using a soluble vascular endothelial growth factor receptor

    Pengnian Lin;Sabita Sankar;Si Qing Shan;Mark W. Dewhirst

  • Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation.

    S. Werner;W. Weinberg;Xiang Liao;K. G. Peters

  • Impaired Collateral Vessel Development Associated With Reduced Expression of Vascular Endothelial Growth Factor in ApoE−/− Mice

    Thierry Couffinhal;Marcy Silver;Marianne Kearney;Alison Sullivan

  • Tyrosine 1101 of Tie2 Is the Major Site of Association of p85 and Is Required for Activation of Phosphatidylinositol 3-Kinase and Akt

    Christopher D. Kontos;Thomas P. Stauffer;Wen-Pin Yang;John D. York

  • Functional significance of Tie2 signaling in the adult vasculature.

    Kevin G Peters;Christopher D Kontos;P Charles Lin;Adrianne L Wong

  • VEGF enhances pulmonary vasculogenesis and disrupts lung morphogenesis in vivo.

    Xin Zeng;Susan E. Wert;Robert Federici;Kevin G. Peters

Frequent Co-Authors

Lewis T. Williams
Lewis T. Williams University of California, San Francisco
Keith M. Channon
Keith M. Channon University of Oxford
Dietmar Vestweber
Dietmar Vestweber Max Planck Society
Mark W. Dewhirst
Mark W. Dewhirst Duke University
Peter A. Campochiaro
Peter A. Campochiaro Johns Hopkins University School of Medicine
Sabine Werner
Sabine Werner ETH Zurich
Didier Y. R. Stainier
Didier Y. R. Stainier Max Planck Society
Feng Wang
Feng Wang University of California, Berkeley
Jaime Escobedo
Jaime Escobedo Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your studies in Biology and Biochemistry can open doors to a variety of healthcare career paths. Many students now choose flexible learning by enrolling in online degree programs, making it easier to balance work and study. If you are interested in patient data and insurance claims, understanding the job outlook for medical billing and coding can help you decide if this fast-growing administrative role is right for you.

For those seeking a leadership or management role in healthcare, pursuing an online health information management degree can provide essential skills in managing patient records and health systems. If nutrition is your passion, many universities also offer the cheapest online nutrition degree programs for both current professionals and career changers.

Additionally, those interested in technology and patient care may consider online ultrasound tech programs, which combine biology fundamentals with real-world clinical skills. Exploring these online degrees can help you find a healthcare career path that fits your goals and lifestyle.

Best Scientists Citing Kevin G. Peters

Trending Scientists